Federated Hermes Inc. Sells 42,916 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Federated Hermes Inc. trimmed its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 33.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 83,766 shares of the company's stock after selling 42,916 shares during the quarter. Federated Hermes Inc. owned 0.18% of Avanos Medical worth $1,334,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Illinois Municipal Retirement Fund increased its holdings in shares of Avanos Medical by 3.1% in the 4th quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock worth $402,000 after purchasing an additional 748 shares in the last quarter. Pitcairn Co. increased its holdings in Avanos Medical by 13.6% in the 4th quarter. Pitcairn Co. now owns 17,290 shares of the company's stock worth $275,000 after buying an additional 2,074 shares in the last quarter. US Bancorp DE raised its position in Avanos Medical by 18.0% in the 4th quarter. US Bancorp DE now owns 14,093 shares of the company's stock worth $224,000 after buying an additional 2,147 shares during the last quarter. New York State Teachers Retirement System lifted its stake in Avanos Medical by 4.0% during the 4th quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock valued at $1,197,000 after acquiring an additional 2,921 shares during the period. Finally, Quantbot Technologies LP purchased a new stake in shares of Avanos Medical during the 4th quarter valued at about $64,000. 95.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Avanos Medical Stock Performance

Shares of AVNS traded up $0.34 during trading hours on Friday, hitting $12.40. The stock had a trading volume of 458,797 shares, compared to its average volume of 326,603. The firm has a market capitalization of $570.62 million, a PE ratio of 36.48 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 12 month low of $11.90 and a 12 month high of $25.36. The stock has a fifty day moving average price of $14.40 and a 200 day moving average price of $17.14.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. The firm had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. Analysts anticipate that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Insider Transactions at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares in the company, valued at $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 2.64% of the stock is currently owned by company insiders.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.